AzTrials
AzTrials

Drug UseTASANCT02457949

The Impact of Alternative Social Assistance Disbursement on Drug-related Harm

A study testing Non-synchronized social assistance receipt and cheque divided into two equal disbursements in people with Drug Use, run by University of British Columbia at 1 site in Canada.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study evaluates whether altering the timing and frequency of social assistance disbursement reduces drug related-harms that increase on the days surrounding monthly synchronized government social assistance cheque issue. Read more about this study

Who is it for?
Ages 19 to 64 yearsHealthy volunteers can take part
Conditions the study is for
Drug Use
What is being tested?
Non-synchronized social assistance receipt and cheque divided into two equal disbursements
Could I receive a placebo?
No, everyone receives an active treatment
How many people
194 participants
Where
1 siteCanada
Study dates
27 Oct 2015to 30 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 64 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • be ≥19 years of age or older
  • reside in greater Vancouver, Canada
  • report regular use of illicit drugs other than cannabis
  • receive monthly provincial income assistance
  • are not currently administered (where cheque issue/money is externally managed)
  • be eligible and willing to be a client of the local credit union who will administer the intervention
Show all 9Show fewer
  • report intensified drug use around government cheque issue days
  • provide written informed consent
  • be willing to comply with study procedures

Who cannot join

  • plan to relocate outside Vancouver
  • have plans to discontinue income assistance

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • British Columbia Centre on Substance Use

    Vancouver, British Columbia, V6Z 2A9

Other trials in Canada

About this study

Official title: The Impact of Alternative Social Assistance Disbursement on Drug-Related Harm: a Randomized Control Trial

This study evaluates whether altering the timing and frequency of social assistance disbursement reduces drug related-harms that increase on the days surrounding monthly synchronized government social assistance cheque issue.

Read the detailed description

Coordinated monthly income assistance payments, while seeking to alleviate poverty, can also have negative and unintended impacts, particularly among people who use illicit drugs (PWUD). Observational research has identified escalations in drug-related harm coinciding with monthly assistance payments, such as overdose, treatment interruption, hospital admissions and public disorder. This project varies the timing and frequency of income assistance disbursement, and evaluates whether varying income assistance disbursement reduces drug-related harm coinciding with coordinated income assistance.

Conducted among 273 PWUD, participants will be allocated for 6 income assistance cycles to a control or one of two intervention arms. Participants in the control arm will receive payments according to the existing monthly government schedule. Participants in the intervention arm will receive their income assistance: (1) monthly on a day different from government cheque issue; or (2) semi-monthly on days different from government cheque issue. The intervention will be evaluated using qualitative and quantitative methods for its impact on drug use and related harms.

Conditions
Drug Use
Being tested
Non-synchronized social assistance receipt, cheque divided into two equal disbursements
Keywords
Social Assistance, Drug Use, Drug-Related harm

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Non-synchronized social assistance receiptOther

    Also called Staggered

    Social assistance disbursement outside government cheque issue week

  • cheque divided into two equal disbursementsOther

    Also called Split

    Social assistance disbursement divided into two equal payments

Study groups in NCT02457949
Study groupRoleWhat they receive
Treatment As Usual (TAU)No interventionReceipt of social assistance on government cheque issue days for 6 income assistance cycles (approx 26 weeks).
Staggered ArmExperimentalReceipt of social assistance once monthly on a randomly assigned day that does not fall during the week of government cheque issue (Non-synchronized social assistance receipt), for 6 income assistance cycles (approx 26 weeks).
Receives: Other: Non-synchronized social assistance receipt
Staggered and Split ArmExperimentalReceipt of social assistance twice monthly on equally spaced randomly assigned days that do not fall during the week of government cheque issue (Non-synchronized social assistance receipt, cheque divided into two equal disbursements), for 6 income assistance cycles (approx 26 weeks).
Receives: Other: Non-synchronized social assistance receipt; Other: cheque divided into two equal disbursements

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Illicit drug use on government cheque issue days

    Timeline Follow Back (TLFB) assessed increase of drug use defined as an increase in the frequency of drug use of at least 40% or an increase in the number of drugs used during the 3 days beginning with government cheque issue day, compared to non-cheque issue days.

    Measured: 26 weeks

Secondary outcomes (4)
  1. Illicit drug use on non-government cheque issue days

    Timeline Follow Back (TLFB) assessed increase of drug use defined as an increase in the frequency of drug use of at least 40% or an increase in the number of drugs used during the 3 days beginning with individual cheque issue day (among intervention participants), compared to non-cheque issue days.

    Measured: 26 weeks

  2. Hospital admissions on government cheque issue days

    Emergency Department, Emergency Department Mental Health and substance use hospitalizations in the three days beginning with government cheque issue day compared to non-cheque issue days.

    Measured: 26 weeks

  3. Overdose

    Self-reported non-fatal overdose and hospital record verified fatal overdose on the three days beginning with government cheque issue day compared to non-cheque issue days.

    Measured: 26 weeks

  4. Police service utilization

    Self-reported and police record-verified interactions with police or use of police services on the three days beginning with government cheque issue day compared to non-cheque issue days.

    Measured: 26 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2015 (estimated)
  2. Study start27 Oct 2015
  3. Primary completion2 Jan 2019
  4. Study completion30 Sep 2019

Why it stopped: Interim analyses produced signal of intervention efficacy for primary outcomes and weaker signal of increased exposure to violence. Therefore, DSMC recommended stopping recruitment in May 2018. Enrolled participants completed intervention by Aug 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
194 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02457949
Sponsor's protocol ID
H14-02401
Acronym
TASA
Status last verified
Nov 2020
First submitted
13 May 2015
Last updated
17 Nov 2020
Results posted
No
Data monitoring committee
Yes

Publications

  • Klaire S, Choi J, Laing A, Richardson L. Impact of alternative income assistance disbursement on substance use disorder treatment adherence among people who use drugs. Am J Drug Alcohol Abuse. 2025;51(3):383-394. doi: 10.1080/00952990.2025.2494112. Epub 2025 May 7.

    PubMed 40334114
  • Robinson K, Laing A, Choi J, Richardson L. Effect of modified income assistance payment schedules on substance use service access: Evidence from an experimental study. Int J Drug Policy. 2024 Feb;124:104293. doi: 10.1016/j.drugpo.2023.104293. Epub 2024 Jan 5.

    PubMed 38183858
  • Richardson L, Laing A, Choi J, Nosova E, Milloy MJ, Marshall BD, Singer J, Wood E, Kerr T. Effect of alternative income assistance schedules on drug use and drug-related harm: a randomised controlled trial. Lancet Public Health. 2021 May;6(5):e324-e334. doi: 10.1016/S2468-2667(21)00023-2. Epub 2021 Apr 12.

    PubMed 33857455
  • Mendell J, Richardson L. Integrated knowledge translation to strengthen public policy research: a case study from experimental research on income assistance receipt among people who use drugs. BMC Public Health. 2021 Jan 18;21(1):153. doi: 10.1186/s12889-020-10121-9.

    PubMed 33461522
  • Richardson L, Laing A, Milloy MJ, Maynard R, Nosyk B, Marshall B, Grafstein E, Daly P, Wood E, Montaner J, Kerr T. Protocol of the impact of alternative social assistance disbursement on drug-related harm (TASA) study: a randomized controlled trial to evaluate changes to payment timing and frequency among people who use illicit drugs. BMC Public Health. 2016 Jul 29;16:668. doi: 10.1186/s12889-016-3304-6.

    PubMed 27473400

Questions about this trial

What is this clinical trial studying?

A study testing Non-synchronized social assistance receipt and cheque divided into two equal disbursements in people with Drug Use, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 17 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Interim analyses produced signal of intervention efficacy for primary outcomes and weaker signal of increased exposure to violence. Therefore, DSMC recommended stopping recruitment in May 2018. Enrolled participants completed intervention by Aug 2018). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Illicit drug use on government cheque issue days (time frame: 26 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02457949, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in